96. クローン病 Crohn disease Clinical trials / Disease details
臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01624376 (ClinicalTrials.gov) | June 2012 | 14/6/2012 | Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease | A Randomized, Double-blind, Placebo-controlled Phase I/IIa Study in Patients With Abdominal or Perianal Fistulizing Crohn's Disease to Explore the Safety, Tolerability and Preliminary Efficacy of Locally Administered DLX105. | Fistulizing Crohn's Disease | Drug: DLX105;Drug: Placebo | Delenex Therapeutics AG | NULL | Completed | 18 Years | 65 Years | Both | 18 | Phase 2 | Switzerland |